Eradication of <i>Candida albicans</i> Biofilm Viability: In Vitro Combination Therapy of Cationic Carbosilane Dendrons Derived from 4-Phenylbutyric Acid with AgNO<sub>3</sub> and EDTA
<i>Candida albicans</i> is a human pathogen of significant clinical relevance. This pathogen is resistant to different drugs, and most clinical antifungals are not effective against the prevention and treatment of <i>C. albicans</i> infections. As with other microorganisms, i...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/7/7/574 |
id |
doaj-9e6a89adbeda41beae91ed88a1be9c41 |
---|---|
record_format |
Article |
spelling |
doaj-9e6a89adbeda41beae91ed88a1be9c412021-07-23T13:49:16ZengMDPI AGJournal of Fungi2309-608X2021-07-01757457410.3390/jof7070574Eradication of <i>Candida albicans</i> Biofilm Viability: In Vitro Combination Therapy of Cationic Carbosilane Dendrons Derived from 4-Phenylbutyric Acid with AgNO<sub>3</sub> and EDTANatalia Gómez-Casanova0Tania Lozano-Cruz1Juan Soliveri2Rafael Gomez3Paula Ortega4José Luis Copa-Patiño5Irene Heredero-Bermejo6Department of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871 Alcalá de Henares, SpainDepartment of Organic and Inorganic Chemistry, Research Institute in Chemistry, University of Alcalá, “Andrés M. del Río” (IQAR), 28871 Alcalá de Henares, SpainDepartment of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871 Alcalá de Henares, SpainDepartment of Organic and Inorganic Chemistry, Research Institute in Chemistry, University of Alcalá, “Andrés M. del Río” (IQAR), 28871 Alcalá de Henares, SpainDepartment of Organic and Inorganic Chemistry, Research Institute in Chemistry, University of Alcalá, “Andrés M. del Río” (IQAR), 28871 Alcalá de Henares, SpainDepartment of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871 Alcalá de Henares, SpainDepartment of Biomedicine and Biotechnology, Faculty of Pharmacy, University of Alcalá, 28871 Alcalá de Henares, Spain<i>Candida albicans</i> is a human pathogen of significant clinical relevance. This pathogen is resistant to different drugs, and most clinical antifungals are not effective against the prevention and treatment of <i>C. albicans</i> infections. As with other microorganisms, it can produce biofilms that serve as a barrier against antifungal agents and other substances, contributing to infection in humans and environmental tolerance of this microorganism. Thus, resistances and biofilm formation make treatment difficult. In addition, the complete eradication of biofilms in implants, catheters and other medical devices, is challenging and necessary to prevent relapses of candidemia. Therefore, it is a priority to find new molecules or combinations of compounds with anti-<i>Candida</i> biofilm activity. Due to the difficulty of treating and removing biofilms, the aim of this study was to evaluate the in vitro ability of different generation of cationic carbosilane dendrons derived from 4-phenylbutyric acid, ArCO<sub>2</sub>G<sub>n</sub>(SNMe<sub>3</sub>I)<sub>m</sub>, to eradicate <i>C. albicans</i> biofilms. Here, we assessed the antifungal activity of the second generation dendron ArCO2G<sub>2</sub>(SNMe<sub>3</sub>I)<sub>4</sub> against <i>C. albicans</i> cells and established biofilms since it managed to seriously damage the membrane. In addition, the combinations of the second generation dendron with AgNO<sub>3</sub> or EDTA eradicated the viability of biofilm cells. Alterations were observed by scanning electron microscopy and cytotoxicity was assessed on HeLa cells. Our data suggest that the dendritic compound ArCO<sub>2</sub>G<sub>2</sub>(SNMe<sub>3</sub>I)<sub>4</sub> could represent an alternative to control the infections caused by this pathogen.https://www.mdpi.com/2309-608X/7/7/574<i>Candida albicans</i>carbosilane dendronsilver nitrateEDTAbiofilmsynergy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Natalia Gómez-Casanova Tania Lozano-Cruz Juan Soliveri Rafael Gomez Paula Ortega José Luis Copa-Patiño Irene Heredero-Bermejo |
spellingShingle |
Natalia Gómez-Casanova Tania Lozano-Cruz Juan Soliveri Rafael Gomez Paula Ortega José Luis Copa-Patiño Irene Heredero-Bermejo Eradication of <i>Candida albicans</i> Biofilm Viability: In Vitro Combination Therapy of Cationic Carbosilane Dendrons Derived from 4-Phenylbutyric Acid with AgNO<sub>3</sub> and EDTA Journal of Fungi <i>Candida albicans</i> carbosilane dendron silver nitrate EDTA biofilm synergy |
author_facet |
Natalia Gómez-Casanova Tania Lozano-Cruz Juan Soliveri Rafael Gomez Paula Ortega José Luis Copa-Patiño Irene Heredero-Bermejo |
author_sort |
Natalia Gómez-Casanova |
title |
Eradication of <i>Candida albicans</i> Biofilm Viability: In Vitro Combination Therapy of Cationic Carbosilane Dendrons Derived from 4-Phenylbutyric Acid with AgNO<sub>3</sub> and EDTA |
title_short |
Eradication of <i>Candida albicans</i> Biofilm Viability: In Vitro Combination Therapy of Cationic Carbosilane Dendrons Derived from 4-Phenylbutyric Acid with AgNO<sub>3</sub> and EDTA |
title_full |
Eradication of <i>Candida albicans</i> Biofilm Viability: In Vitro Combination Therapy of Cationic Carbosilane Dendrons Derived from 4-Phenylbutyric Acid with AgNO<sub>3</sub> and EDTA |
title_fullStr |
Eradication of <i>Candida albicans</i> Biofilm Viability: In Vitro Combination Therapy of Cationic Carbosilane Dendrons Derived from 4-Phenylbutyric Acid with AgNO<sub>3</sub> and EDTA |
title_full_unstemmed |
Eradication of <i>Candida albicans</i> Biofilm Viability: In Vitro Combination Therapy of Cationic Carbosilane Dendrons Derived from 4-Phenylbutyric Acid with AgNO<sub>3</sub> and EDTA |
title_sort |
eradication of <i>candida albicans</i> biofilm viability: in vitro combination therapy of cationic carbosilane dendrons derived from 4-phenylbutyric acid with agno<sub>3</sub> and edta |
publisher |
MDPI AG |
series |
Journal of Fungi |
issn |
2309-608X |
publishDate |
2021-07-01 |
description |
<i>Candida albicans</i> is a human pathogen of significant clinical relevance. This pathogen is resistant to different drugs, and most clinical antifungals are not effective against the prevention and treatment of <i>C. albicans</i> infections. As with other microorganisms, it can produce biofilms that serve as a barrier against antifungal agents and other substances, contributing to infection in humans and environmental tolerance of this microorganism. Thus, resistances and biofilm formation make treatment difficult. In addition, the complete eradication of biofilms in implants, catheters and other medical devices, is challenging and necessary to prevent relapses of candidemia. Therefore, it is a priority to find new molecules or combinations of compounds with anti-<i>Candida</i> biofilm activity. Due to the difficulty of treating and removing biofilms, the aim of this study was to evaluate the in vitro ability of different generation of cationic carbosilane dendrons derived from 4-phenylbutyric acid, ArCO<sub>2</sub>G<sub>n</sub>(SNMe<sub>3</sub>I)<sub>m</sub>, to eradicate <i>C. albicans</i> biofilms. Here, we assessed the antifungal activity of the second generation dendron ArCO2G<sub>2</sub>(SNMe<sub>3</sub>I)<sub>4</sub> against <i>C. albicans</i> cells and established biofilms since it managed to seriously damage the membrane. In addition, the combinations of the second generation dendron with AgNO<sub>3</sub> or EDTA eradicated the viability of biofilm cells. Alterations were observed by scanning electron microscopy and cytotoxicity was assessed on HeLa cells. Our data suggest that the dendritic compound ArCO<sub>2</sub>G<sub>2</sub>(SNMe<sub>3</sub>I)<sub>4</sub> could represent an alternative to control the infections caused by this pathogen. |
topic |
<i>Candida albicans</i> carbosilane dendron silver nitrate EDTA biofilm synergy |
url |
https://www.mdpi.com/2309-608X/7/7/574 |
work_keys_str_mv |
AT nataliagomezcasanova eradicationoficandidaalbicansibiofilmviabilityinvitrocombinationtherapyofcationiccarbosilanedendronsderivedfrom4phenylbutyricacidwithagnosub3subandedta AT tanialozanocruz eradicationoficandidaalbicansibiofilmviabilityinvitrocombinationtherapyofcationiccarbosilanedendronsderivedfrom4phenylbutyricacidwithagnosub3subandedta AT juansoliveri eradicationoficandidaalbicansibiofilmviabilityinvitrocombinationtherapyofcationiccarbosilanedendronsderivedfrom4phenylbutyricacidwithagnosub3subandedta AT rafaelgomez eradicationoficandidaalbicansibiofilmviabilityinvitrocombinationtherapyofcationiccarbosilanedendronsderivedfrom4phenylbutyricacidwithagnosub3subandedta AT paulaortega eradicationoficandidaalbicansibiofilmviabilityinvitrocombinationtherapyofcationiccarbosilanedendronsderivedfrom4phenylbutyricacidwithagnosub3subandedta AT joseluiscopapatino eradicationoficandidaalbicansibiofilmviabilityinvitrocombinationtherapyofcationiccarbosilanedendronsderivedfrom4phenylbutyricacidwithagnosub3subandedta AT ireneherederobermejo eradicationoficandidaalbicansibiofilmviabilityinvitrocombinationtherapyofcationiccarbosilanedendronsderivedfrom4phenylbutyricacidwithagnosub3subandedta |
_version_ |
1721287594011000832 |